银杏苦内酯B(BN52021)为"国宝"银杏叶提取物中非常重要的有效成分之一,是炎性介质血小板活化因子(PAF)的强拮抗剂,具有抗炎、抗休克和抗血栓形成等多种药理作用。BN52021在治疗急性胰腺炎的实验研究中也表现出显著的疗效,而且较其它国外合成的类似拮抗剂有明显优势,但其作用机制尚缺乏深入研究,其作用的具体分子机制(细胞信号转导机制)国内外文献尚未见报道。本项目采用分子生物学技术研究BN520
{{i.achievement_title}}
数据更新时间:2023-05-31
DNAgenie: accurate prediction of DNA-type-specific binding residues in protein sequences
黄曲霉毒素B1检测与脱毒方法最新研究进展
Quasispecies characteristic in "a" determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case-control study.
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
银杏苦内酯B对SAP胰腺微血管内皮细胞PAFR的影响及机制
急性重症胰腺炎中西药治疗机制的探讨(动物实验研究)
PARP调控NF-κB通路参与重症急性胰腺炎肾上腺损伤的机制研究
通里攻下法治疗重症急性胰腺炎中性粒细胞线粒体凋亡通路异常的机制